NOVARTIS AG (NVSEF)
Clinical trial NCT07630961 updates: 1. start date: 2026-06-15 → 2026-06-23 2. completion date: 2028-01-14 → 2028-01-22 3. primary completion date: 2028-01-14 → 2028-01-22
Clinical trial NCT07630961 updates: 1. start date: 2026-06-15 → 2026-06-23 2. completion date: 2028-01-14 → 2028-01-22 3. primary completion date: 2028-01-14 → 2028-01-22
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical